These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15725085)

  • 1. Changes in gene expression profiles of multiple myeloma cells induced by arsenic trioxide (ATO): possible mechanisms to explain ATO resistance in vivo.
    Zhou P; Kalakonda N; Comenzo RL
    Br J Haematol; 2005 Mar; 128(5):636-44. PubMed ID: 15725085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in glutathione levels and apoptotic regulators are associated with acquisition of arsenic trioxide resistance in multiple myeloma.
    Matulis SM; Morales AA; Yehiayan L; Lee KP; Cai Y; Boise LH
    PLoS One; 2012; 7(12):e52662. PubMed ID: 23285138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactive oxygen species are not required for an arsenic trioxide-induced antioxidant response or apoptosis.
    Morales AA; Gutman D; Cejas PJ; Lee KP; Boise LH
    J Biol Chem; 2009 May; 284(19):12886-95. PubMed ID: 19279006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic trioxide-mediated growth inhibition of myeloma cells is associated with an extrinsic or intrinsic signaling pathway through activation of TRAIL or TRAIL receptor 2.
    Wu X; Shi J; Wu Y; Tao Y; Hou J; Meng X; Hu X; Han Y; Jiang W; Tang S; Zangari M; Tricot G; Zhan F
    Cancer Biol Ther; 2010 Dec; 10(11):1201-14. PubMed ID: 20953137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulforaphane synergistically enhances the cytotoxicity of arsenic trioxide in multiple myeloma cells via stress-mediated pathways.
    Doudican NA; Wen SY; Mazumder A; Orlow SJ
    Oncol Rep; 2012 Nov; 28(5):1851-8. PubMed ID: 22922937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of heme oxygenase-1 enhances anti-cancer effects of arsenic trioxide on glioma cells.
    Liu Y; Liang Y; Zheng T; Yang G; Zhang X; Sun Z; Shi C; Zhao S
    J Neurooncol; 2011 Sep; 104(2):449-58. PubMed ID: 21327864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Darinaparsin induces a unique cellular response and is active in an arsenic trioxide-resistant myeloma cell line.
    Matulis SM; Morales AA; Yehiayan L; Croutch C; Gutman D; Cai Y; Lee KP; Boise LH
    Mol Cancer Ther; 2009 May; 8(5):1197-206. PubMed ID: 19417148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic trioxide uses caspase-dependent and caspase-independent death pathways in myeloma cells.
    McCafferty-Grad J; Bahlis NJ; Krett N; Aguilar TM; Reis I; Lee KP; Boise LH
    Mol Cancer Ther; 2003 Nov; 2(11):1155-64. PubMed ID: 14617789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of mitochondrial protein translation sensitizes melanoma cells to arsenic trioxide cytotoxicity via a reactive oxygen species dependent mechanism.
    Bowling BD; Doudican N; Manga P; Orlow SJ
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):37-43. PubMed ID: 18297286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Realgar nanoparticles versus ATO arsenic compounds induce in vitro and in vivo activity against multiple myeloma.
    Cholujova D; Bujnakova Z; Dutkova E; Hideshima T; Groen RW; Mitsiades CS; Richardson PG; Dorfman DM; Balaz P; Anderson KC; Jakubikova J
    Br J Haematol; 2017 Dec; 179(5):756-771. PubMed ID: 29048129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines.
    Kajiguchi T; Yamamoto K; Iida S; Ueda R; Emi N; Naoe T
    Cancer Sci; 2006 Jun; 97(6):540-5. PubMed ID: 16734734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genistein selectively potentiates arsenic trioxide-induced apoptosis in human leukemia cells via reactive oxygen species generation and activation of reactive oxygen species-inducible protein kinases (p38-MAPK, AMPK).
    Sánchez Y; Amrán D; Fernández C; de Blas E; Aller P
    Int J Cancer; 2008 Sep; 123(5):1205-14. PubMed ID: 18546268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic and functional analyses reveal a dual molecular mechanism underlying arsenic-induced apoptosis in human multiple myeloma cells.
    Ge F; Lu XP; Zeng HL; He QY; Xiong S; Jin L; He QY
    J Proteome Res; 2009 Jun; 8(6):3006-19. PubMed ID: 19364129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heme oxygenase-1 silencing increases the sensitivity of human osteosarcoma MG63 cells to arsenic trioxide.
    Zhong L; Wang Y; Li W; Gu J; Li X; Wang X; Yue Z; Mu Y; Bai J; Li R; Zhang H
    Mol Cell Biochem; 2014 Jul; 392(1-2):135-44. PubMed ID: 24676542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction underlie apoptosis induced by resveratrol and arsenic trioxide in A549 cells.
    Gu S; Chen C; Jiang X; Zhang Z
    Chem Biol Interact; 2016 Feb; 245():100-9. PubMed ID: 26772155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of arsenic trioxide-induced apoptosis in HeLa cells by N-acetylcysteine.
    Han YH; Kim SZ; Kim SH; Park WH
    Mol Cells; 2008 Jul; 26(1):18-25. PubMed ID: 18511884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BH3-only proteins Noxa, Bmf, and Bim are necessary for arsenic trioxide-induced cell death in myeloma.
    Morales AA; Gutman D; Lee KP; Boise LH
    Blood; 2008 May; 111(10):5152-62. PubMed ID: 18354037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective apoptosis of multiple myeloma cells in primary samples induced by arsenic trioxide.
    Reberšek K; Žontar DM; Černelč P; Podgornik H
    Hematology; 2014 Sep; 19(6):346-51. PubMed ID: 24165827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenic trioxide induces human pulmonary fibroblast cell death via increasing ROS levels and GSH depletion.
    You BR; Park WH
    Oncol Rep; 2012 Aug; 28(2):749-57. PubMed ID: 22684917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased growth-inhibitory and cytotoxic activity of arsenic trioxide in head and neck carcinoma cells with functional p53 deficiency and resistance to EGFR blockade.
    Boyko-Fabian M; Niehr F; Distel L; Budach V; Tinhofer I
    PLoS One; 2014; 9(6):e98867. PubMed ID: 24927258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.